Gene therapy delivery directly to the brain for AADC deficiency
PTC Therapeutics’ gene therapy delivered directly to the brain is yielding life-changing results in children with AADC deficiency.
RSV vaccines improve on technology but contend with a post-Covid world
Post-Covid changes including social distancing measures and seasonal shifts have challenged RSV vaccine development projects.
Clover Biopharmaceuticals’ Covid-19 jab could help boost global vaccine supply
The clinical-stage company has announced that its Covid-19 vaccine candidate, SCB-2019, is 67% effective against the virus.
Rare Diseases 2021: maintaining the human element in decentralised trials
AGTC’s director of patient enrollment discusses the importance of the human touch in decentralised rare disease clinical trials.
Merck and Ridgeback’s molnupiravir rollout difficult to map in uncertain Covid-19 landscape
Questions about oral molnupiravir's deployment still loom large as clinicians await crucial late-stage trial results.
Latest Deals
-
Elligo Health ResearchMergers & Acquisitions $135M
-
Reify HealthCapital Raising $220M
-
CertaraMergers & Acquisitions $310M
-
ParexelMergers & Acquisitions $8.5BN
-
Elligo Health ResearchMergers & Acquisitions $135M
-
Reify HealthCapital Raising $220M
-
CertaraMergers & Acquisitions $310M
-
ParexelMergers & Acquisitions $8.5BN
Weekly chart
Cloud deals, company filing mentions and jobs in the pharma sector in Q2 2021 and change from Q2 2020
Change from Q2 2020 in brackets
| Indicator | Count |
|---|---|
| Financing deals | 3 (−1▼) |
| M&As | 1 (0) |
| Partnership deals | 1 (0) |
| Grants | 0 (−4▼) |
| Company filings mentions | 38 (−11▼) |
| Jobs | 5,269 (+3,358▲) |
Latest News
Elligo Health acquires clinical services firm ClinEdge for $135m
The acquisition, which also includes GuideStar Research and BTC of New Bedford, was financed through investor funding.
Astex Pharmaceuticals reports updated Phase III data of Inqovi for MDS
The most common adverse events linked to Inqovi reported in the trial were in line with parenteral hypomethylating agent treatment.
Valneva starts recruitment of adolescents for Covid-19 vaccine trial in UK
The Phase III trial plans to enrol nearly 660 adolescent subjects aged 12 to 17 years in the initial stage.
Appili concludes subject enrolment in Phase III Covid-19 drug trial
In November 2020, Appili commenced the trial for evaluating oral Avigan/Reeqonus as a potential at-home treatment for Covid-19.
Latest Themes
Inside Cervest’s plan to map the world’s climate risk
Envirotech startup Cervest is building an AI platform that can map the world's climate risk and provide businessses with climate intelligence, as Robert Scammell discovers.
Show us the money: Sustainable finance tech for COP26 to think about
COP26 is likely to bring more power to the net-zero movement. But what changes can sustainable technology bring?
Inside the $45bn robotics market: The taxonomy and value chain behind today’s robot helpers
The robotics industry was worth $45bn in 2020, and by 2030, it will have grown at a CAGR of 29% to $568bn.
Waning Covid-19 vaccine efficacy: what does the data show?
While Covid-19 vaccines’ protection does appear to wane, most experts agree that universal booster rollouts aren’t needed yet.
Number of resumed trials very gradually increases
As of 17 September, the number of resumed clinical trials tracked by GlobalData's Pharma Intelligence Centre stands at 1,095.
Oral molnupiravir has at least 350 patients left to recruit in Phase III Covid-19 trial
As breakthrough mild-to-moderate Covid-19 cases continue to rise, all eyes are on Merck and Ridgeback Biotherapeutics’ antiviral.
Covid-19 mRNA vaccines for kids likely to be safe and effective but vigilance needed
Experts point to uncharted factors in Covid-19 vaccine research in kids as mRNA jab developers reveal their authorisation plans.
Rare Diseases 2021: GlobalData’s Bonnie Bain on embracing disruption in pharma
GlobalData’s head of pharma analyses whether Covid-19 is a catalyst for lasting change in clinical research.
Expert Commentary & Analysis
View MoreToo many adults in the US remain unvaccinated to shift focus to vaccinating children
Several factors mean it will be a delicate measure to broadly mandate vaccinating children in...
Delta Variant in US Children May Place Millions of Adults in Nursing Homes at Risk
Rising Delta variant cases in school-aged children could increase transmission to adults living in nursing...
ESMO 2021: positive data supports Enhertu use over Kadcyla in breast cancer treatment
Recent trial results for Enhertu could lead to a shift in the HER2-positive metastatic breast...
ESMO 2021: Phase III data shows Roche’s Tecentriq addressing high unmet need in NSCLC
Updated results from a Phase III trial for Tecentriq (atezolizumab) could change the non-small cell...